Key Statistical Concepts in Cancer Research

Qian Shi, PhD, and Daniel J. Sargent, PhD

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Qian Shi, PhD, and Daniel J. Sargent, PhD The authors are affiliated with […]

Review of Treatment Options for Oligometastatic Non–Small Cell Lung Cancer

Michael R. Folkert, MD, PhD, and Robert Timmerman, MD

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Michael R. Folkert, MD, PhD, and Robert Timmerman, MD The authors are affiliated […]

The Shifting Paradigm for Transfusion of Red Blood Cells

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Jeffrey L. Carson, MD, Richard C. Reynolds Professor of Medicine, Chief, Division of General Internal Medicine, Rutgers Robert […]

Rituximab Maintenance in Follicular Lymphoma

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Paul M. Barr, MD, Assistant Professor, Department of Medicine, University of Rochester, Medical Center, Rochester, New York […]

The National Cancer Institute’s Experimental Therapeutics Clinical Trials Network

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   S. Percy Ivy, MD, Associate Chief, Cancer Therapy Evaluation Program, Investigational Drug Branch, Division of Cancer Treatment […]

The Role of Third-Generation Epithelial Growth Factor Receptor Inhibitors in Non–Small Cell Lung Cancer

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Lecia V. Sequist, MD, MPH, Associate Professor, Harvard Medical School, Boston, Massachusetts   H&O  How did […]

Hepatocellular Carcinoma: Current Questions and Future Directions

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Robert G. Gish, MD, Clinical Professor of Medicine (Consultant), Stanford Hospital and Medical Center, Stanford, California, Clinical […]

Counterpoints: Do Patients With Multiple Myeloma Need Maintenance Treatment?

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Multiple myeloma is an incurable disease, and patients who respond to treatment eventually […]

Hem/Onc News

Devon Schuyler, Kathryn Turner PhD

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   FDA Approves Palbociclib for Breast Cancer Palbociclib (Ibrance, Pfizer) has received accelerated approval […]

Letter From the Editor

Bruce D. Cheson, MD

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3   Lies and Truth If you tell the truth, you don’t have to remember […]

Back to Archive